All articles tagged with #international pricing
President Trump plans to pressure drugmakers to lower US drug prices by potentially raising prices in other countries, aiming to make US prices comparable to Europe and peer nations, though legal and practical challenges remain.
Prescription weight-loss drugs, such as Wegovy, Mounjaro, and Ozempic, cost significantly more in the United States compared to other countries. For example, Wegovy is four times more expensive in the US than in Germany and the Netherlands, while Mounjaro and Ozempic cost three times more in the US than in Japan. The high prices in the US can be attributed to the lack of universal coverage or single-payer health insurance, which limits bargaining power and efficiency. As a result, Americans are being overcharged by drug companies while other countries benefit from lower prices due to free-market economics.